Thu, Jul 27, 2017 | updated 06:54 AM IST

Taking Tamoxifen does not escalate risk of uterine cancer: Study

Updated: Oct 05, 2016 11:22 IST      
Taking Tamoxifen does not escalate risk of uterine cancer: Study

Washington D.C. (USA), Oct. 5 (ANI): A recent study carried out by Loyola Medicine researchers shuns the commonly spread belief that breast cancer drug Tamoxifen could increase the risk of uterine cancer.

The study carried out by Drs. Kathy S. Albain and Ronald K. Potkul enrolled 296 eligible post-menopausal breast patients with a type of early-stage breast cancer called estrogens receptor-positive.

Patients were randomly assigned to take Tamoxifen alone or Tamoxifen plus the hormone progestin.

They were followed and assessed at years two and five.

Researchers predicted that taking progestin would decrease the risk of abnormalities that can develop into uterine cancer.

Such abnormalities occur in the endometrium (inner lining of the uterus).

At year two, the primary time point, researchers evaluated 89 women who took Tamoxifen alone and 80 women who took Tamoxifen plus progestin.

There were five endometrial abnormalities in the Tamoxifen-alone group and one abnormality in the Tamoxifen-plus-progestin group.

This difference was not statistically significant.

All abnormalities were benign.

Only one additional benign abnormality was found at five years. No cancers were detected at two years or five years.

Two years after treatment began, only 6 percent of the patients in the Tamoxifen-alone group, and 3.6 percent in both groups combined had benign endometrial abnormalities.

Based on previous studies, researchers had projected that 30 percent of the women in the Tamoxifen-alone group would show endometrial

abnormalities.

Corresponding author is Kathy S. Albain said the reason the abnormality rate was much lower than expected most likely was due to the study's screening requirements.

All women recruited for the study underwent uterine ultrasound exams before taking tamoxifen.

If the ultrasounds showed a thickening of the inner lining of the uterus greater than 5 mm, a biopsy was performed.

If the biopsy showed an endometrial abnormality, the woman was excluded from the study.

"For women who are concerned about taking tamoxifen to treat or prevent breast cancer, our study suggests that a normal ultrasound before treatment may provide additional reassurance," Albain added.

Tamoxifen is a highly effective drug that is used both to treat breast cancer and help prevent breast cancer in healthy women who are at high

risk of developing the disease.

The first author of the study Ronald K. Potkul said, "However, many women who would benefit from taking tamoxifen fail to do so because they fear getting endometrial cancer. Our study found that for women, who did not have endometrial abnormalities when they began taking Tamoxifen, there was a very low rate of developing pre-malignant conditions."

The median age of the women in the study was 59.5 years.

They underwent endometrial ultrasounds at the beginning of the study and after two years and five years.

After two years, 67 percent of the women in the tamoxifen-alone group had a thickening of the inner lining of the uterus greater than 5 mm, compared with 60 percent of the women in the tamoxifen-plus-progestin group.

This difference was not statistically significant.

All women, who had a thickness greater than 5 mm underwent subsequent biopsies.

The biopsies revealed five cases of endometrial abnormalities in the Tamoxifen group, four cases of proliferative endometrium (more cells

than normal lining the uterus) and one case of simple hyperplasia (non-malignant clumping of cells).

One woman in the Tamoxifen-plus progestin group had an abnormality (proliferative endometrium).

None of the abnormalities in either group developed into uterine cancer.

Although there were more endometrial abnormalities in the Tamoxifen-alone group, the difference was not large enough to be statistically significant.

It would require a follow-up trial with thousands of women to determine whether adding progestin to Tamoxifen truly reduces the risk of uterine cancer.

"These data could potentially reassure certain postmenopausal women who fear endometrial side effects of Tamoxifen, but would otherwise benefit from nstituting this important adjuvant breast cancer and breast cancer chemoprevention therapy. However, validation in a larger trial is needed first before changing practice in all asymptomatic postmenopausal women," researchers concluded.

The multi-center study was published in the Nature journal, Breast Cancer. (ANI)

Rural households at lower risk of inflammatory bowel disease

Updated: Jul 26, 2017 16:33 IST     

Washington D.C. [USA], July 26 (ANI): People, particularly for young children and adolescents, who live in rural areas are at decreased risk of developing inflammatory bowel disease (IBD), according to a new study.

Full Story >>

23% Indian women seek dignity, respect in maternal healthcare

Updated: Jul 26, 2017 12:35 IST     

New Delhi [India], July 26 (ANI): In its campaign to understand the women's want for improved maternal health in India, White Ribbon Alliance India steered the nation-wide campaign 'Hamara Swasthya, Hamari Awaz'.

Full Story >>

New Delhi [India], July 26 (ANI): A 45 year old patient undergoes successful liver transplant at BLK Super Speciality Hospital, after receiving liver from a donor after his cardiac death - what is called as 'Donation After Cardiac Death' or DCD.

Full Story >>

India carries out more than 100 bariatric surgeries a day

Updated: Jul 26, 2017 04:35 IST     

New Delhi [India], July 26 (ANI): India is carrying out more than 100 weight loss surgeries a day.

Full Story >>

Washington D.C. [USA], July 25 (ANI): A study has recently suggested that children, who experience sleep disruptions following violent incidents in neighborhoods, struggle more to learn and perform academic tasks at school.

Full Story >>

World Embryologists Day: Myths and facts about IVF

Updated: Jul 25, 2017 14:34 IST     

New Delhi [India], July 25 (ANI): The birth of a child is a happy occasion for any family and a new chapter in the life of a couple. However, today, there is an increase in the number of couples who are unable to conceive due to many reasons.

Full Story >>

World IVF Day: Celebrating birth of world's first IVF baby

Updated: Jul 25, 2017 12:03 IST     

Gurugram (Haryana) [India], July 25 (ANI): Thirty-nine years ago the world was introduced to its first test-tube baby when Louise Brown was born through the IVF technique at Bourn Hall.

Full Story >>

Washington D.C. [USA], July 25 (ANI): To provide better shield against infection, researchers have devised a new way of producing the seasonal flu vaccine.

Full Story >>

Can eye test help diagnose autism?

Updated: Jul 25, 2017 10:27 IST     

Washington D.C. [USA], July 25 (ANI): Researchers have herald a new tool that helps physicians identify a sub-group of people with Autism spectrum disorders (ASD).

Full Story >>

New Delhi [India], 25 July (ANI): Infertility is on the rise among Indians with 10 to 14% of the population affected by it. The main addition has been the group of career-oriented women who delay childbearing and try for a baby later as compared to women in previous generations.

Full Story >>

Ensure to have healthy heartbeats

Updated: Jul 25, 2017 04:33 IST     

New Delhi [India], July 25 (ANI): With increasing lifestyle problems, Cardiovascular Diseases (CVDs) have emerged as a leading cause of mortality worldwide, followed by cancer.

Full Story >>

World Optometry Congress to bring hope for visually impaired

Updated: Jul 24, 2017 14:40 IST     

New Delhi [India], July 24 (ANI): The world's visually impaired will be the subject of some serious discussion at the forthcoming second World Congress of Optometry in Hyderabad.

Full Story >>

Neuroticism might increase your life span

Updated: Jul 24, 2017 13:25 IST     

Washington D.C. [USA] ,July 24 (ANI): Neuroticism is one of the big five higher-order personality traits in the study of psychology.

Full Story >>

Washington D.C. [USA], July 24 (ANI): Survivors of a stroke or a mini-stroke without early complications have an increased risk of death, another stroke or heart attack (myocardial infarction) for at least five years following the initial stroke.

Full Story >>

Genetic variation may increase tuberculosis susceptibility

Updated: Jul 23, 2017 10:53 IST     

Washington D.C. [USA], July 23 (ANI): Chinese researchers have found that a single change in a gene may increase the risk of tuberculosis.

Full Story >>

This is your brain on depression

Updated: Jul 22, 2017 13:55 IST     

Washington D.C. [USA], July 22 (ANI): Got the blues? According to a recent study, depression can change the structure of your brain.

Full Story >>

Rush-hour pollution may be more harmful than thought

Updated: Jul 22, 2017 10:57 IST     

Washington D.C. [USA], Jul 22 (ANI): Turns out, rush-hour commuters may be in for a double whammy of pollution exposure.

Full Story >>

TRAC, MedGenome announce Cancer Immunotherapy solution

Updated: Jul 22, 2017 06:24 IST     

New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.

Full Story >>

Are some people genetically programmed to be depressed?

Updated: Jul 21, 2017 09:48 IST     

Washington D.C. [USA], Jul 21 (ANI): It's a sombre thought, but it seems that some of us are born more likely to be depressed.

Full Story >>

Washington D.C. [USA], Jul 21 (ANI): A team of researchers has come up with a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests.

Full Story >>